Difference between fenofibrate formulations

Fenofibrate is a third-generation fibric acid derivative indicated as a monotherapy to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein B; to increase high-density lipoprotein cholesterol in patients with primary hyperlipidemia or mixed dyslipidemia; and to reduce triglycerides in patients 12 Fenofibrate and fenofibric acid are Food and Drug Administration (FDA)-approved for the treatment of hypercholesterolemia and mixed dyslipidemias, as well as hypertriglyceridemia. marketed formulations, and is approved for coadministration with a statin

2024-03-29
    Janice vidal marriott
  1. com
  2. Fenoglide
  3. Each capsule contains 67 mg, 134 mg or 200 mg of